Stocks and Investing
Stocks and Investing
Mon, January 10, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Jason Celino Maintained (SNPS) at Buy with Increased Target to $445 on, Jan 10th, 2022
Jason Celino of Keybanc, Maintained "Synopsys, Inc." (SNPS) at Buy with Increased Target from $395 to $445 on, Jan 10th, 2022.
Jason has made no other calls on SNPS in the last 4 months.
There are 5 other peers that have a rating on SNPS. Out of the 5 peers that are also analyzing SNPS, 0 agree with Jason's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Jason
- Blair Abernethy of "Rosenblatt" Maintained at Strong Buy with Increased Target to $385 on, Thursday, December 2nd, 2021
- Charles Shi of "Needham" Maintained at Strong Buy with Increased Target to $370 on, Thursday, December 2nd, 2021
- Gary Mobley of "Wells Fargo" Maintained at Buy with Increased Target to $415 on, Thursday, December 2nd, 2021
- Joe Vruwink of "Baird" Maintained at Buy with Increased Target to $402 on, Thursday, December 2nd, 2021
- John Pitzer of "Credit Suisse" Maintained at Buy with Increased Target to $360 on, Monday, November 29th, 2021
Contributing Sources